Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1372415 | Bioorganic & Medicinal Chemistry Letters | 2010 | 4 Pages |
Abstract
The reductive activation of mitomycin C in aqueous bicarbonate buffer resulted in the formation of a previously unknown compound, characterized as an oxazolidinone derivative of cis-1-hydroxy-2,7-diaminomitosene. This compound is the result of a cyclization reaction of bicarbonate with the aziridine ring of aziridinomitosene, and was observed at bicarbonate concentrations close to those present in physiological plasma.
Graphical abstractThe antitumor drug mitomycin C metabolizes in vitro to an oxazolidinone derivative by a cyclization reaction of the aziridine ring with biocarbonate, the biological buffer.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Manuel M. Paz,